2017-01-26

c-LEcta starts Marketing & Distribution of DENARASE®

DENARASE® is now directly available at c-LEcta. c-LEcta has taken over the product distribution from Sartorius Stedim Biotech GmbH by the end of 2016 and now sells DENARASE® under the same brand name and in identical package sizes. Furthermore, c-LEcta continues to produce the endonuclease in the same production facilities using its patent protected production process in full compliance with cGMP requirements. This process allows to provide DENARASE® in an outstanding product quality and at low prices.

DENARASE® from Serratia marcenses is a highly active nuclease that is used to remove interfering DNA and RNA from fermentation batches e.g. during the production of vaccines and biopharmaceuticals.

 

The advantages of DENARASE® are:

+ Animal product free production

+ endotoxin-free production strain

+ high purity and activity

+ compliance with cGMP

 

If you are interested in testing our DENARASE or if you need further information, please do not hesitate to contact us via denarase@c-lecta.com.